FDA Drug Application (011721) for NEPTAZANE by LEDERLE

Back to FDA Applications sponsored by LEDERLE

Application Number011721
Product Number001
FormTABLET;ORAL
Dosage50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEPTAZANE
Active IngredientMETHAZOLAMIDE



Back to FDA Applications sponsored by LEDERLE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.